Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Not yet recruiting	Not applicable	2024-11-29		NCT06709274

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Guangdong Association of Clinical Trials	20
Nanjing Geneseeq Technology Inc.	2

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Nantong University	Nantong	China	14
Dongguan People's Hospital	Dongguan	China	23
Guangdong Provincial People's Hostpital	Guangzhou	China	1
Guizhou Provincial People's Hospital	Guiyang	China	13
Hunan Cancer Hospital	Changsha	China	87
Jiangsu Cancer Hospital	Nanjing	China	22
Peking University Shenzhen Hospital	Shenzhen	China	21
Shenzhen People's Hospital	Shenzhen	China	25
Sichuan Provincial People's Hospital	Chengdu	China	36
The First People's Hospital of Foshan	Foshan	China	10
The Second Affiliated Hospital of Guangxi Medical University	Nanning	China	6
The Third People's Hospital of Chengdu	Chengdu	China	8
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology	Wuhan	China	6
Xiangya Hospital of Central South University	Changsha	China	36
ZhuJiang Hospital of Southern Medical University	Guangzhou	China	27